Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea.

ABSTRACT: Recent updates in genomic-integrated glioma classification have caused confusion in current clinical practice, as management protocols and health insurance systems are based on evidence from previous diagnostic classifications. The Korean Brain Tumor Society conducted an electronic questionnaire for society members, asking for their ideas on risk group categorization and preferred treatment for each individual diagnosis listed in the new World Health Organization (WHO) classification of gliomas. Additionally, the current off-label drug use (OLDU) protocols for glioma management approved by the Health Insurance Review and Assessment Service (HIRA) in Korea were investigated. A total of 24 responses were collected from 20 major institutes in Korea. A consensus was reached on the dichotomic d

SUBMITTER: Park CK 

PROVIDER: S-EPMC10183254 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature